Posted March 18, 2020 by jennysmith
Cutaneous Leishmaniasis Drugs market was valued at USD 40.5 Million in 2018 and is projected to reach USD 56.1 Million by 2026, growing at a CAGR of 4.23% from 2019 to 2026.
| Contact Email | [email protected] |
| Issued By | VMR |
| Country | United States |
| Categories | Business |
| Tags | cutaneous leishmaniasis drugs |
| Last Updated | March 18, 2020 |